NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18
March 05 2018 - 2:30PM
Business Wire
NantHealth will be exhibiting its Connected
Care solutions at booth #14003
NantHealth (NASDAQ: NH), a next-generation, evidence-based,
personalized healthcare company, will be exhibiting this year at
the Healthcare Information & Management Systems Society Annual
Conference & Exhibition 2018 (HIMSS18) taking place March 5-9
at the Venetian – Palazzo – Sands Expo Center in Las Vegas, NV at
booth #14003.
NantHealth will be presenting “The Future of Device Connectivity
Across the Continuum of Care” in the Population Health Solutions
Lab, Session SL20, on Wednesday, March 7, 2018 at 10:30 AM Pacific
Time. Presenter Wesley Madden BSN RN, VP of Connectivity
Sales, will highlight NantHealth’s Connected Care solutions today,
what the future holds for products in this category, and how this
technology has the potential to dramatically improve care delivery,
clinician satisfaction, and cost reduction efforts.
In addition, NantHealth representatives will be exhibiting
Connected Care, a portfolio of medical device integration (MDI)
products that include:
- DeviceConX™ – The award-winning,
software-based, and vendor-agnostic Medical Device Data System
(MDDS) trusted by hospitals and clinics across the globe to
facilitate the integration of hundreds of medical devices with a
variety of clinical system endpoints (including popular EHRs).
- VitalsConX – A touch-optimized tablet
application that streamlines low-acuity rounding and assessment
workflows by eliminating transcription, accelerating data
availability, and collecting both device data and observations at
the bedside and sending them to the EHR in near real-time.
- HBox® – An IEC60601-compliant fanless
PC appliance that acts as hub to capture and relay medical device
data from hospital, ambulatory, or home settings.
“As patient needs are shaping the future of healthcare,
technology continues to play an integral role in supporting this
shift,” said Wesley Madden. “The Connected Care solutions
NantHealth is showcasing at HIMSS 2018 integrate medical device
data into clinical records and are proven to have an impact on
length of hospital overstays, costly medical errors, provider
dissatisfaction, and suboptimal patient care.”
Visit NantHealth at booth #14003 in the Population Health
Solutions Lab to see a Connected Care demonstration. or attend the
presentation in the Population Health Solutions Lab. To schedule a
private meeting with a sales, product, or marketing representative
please enter your information here.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including, among others, statements regarding the
capabilities and anticipated utility of our GPS Cancer, including
predicting patient response and resistance to therapeutics,
enabling diagnoses by physicians and accelerating efforts to bring
novel combinations of therapeutic agents to cancer patients.
Forward-looking statements are subject to numerous risks and
uncertainties that could cause actual results to differ materially
from currently anticipated results. Factors that may cause future
results to differ materially from management’s current expectations
include, among other things, that GPS Cancer may not perform as
anticipated, that sufficient physicians may not adopt GPS Cancer to
assist their diagnoses or that healthcare payers may not provide
reimbursement for GPS Cancer as expected. Our business is subject
to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our
ability to successfully launch new products and applications;
competition; our sales, marketing and distribution capabilities;
our planned sales, marketing, and research and development
activities; unanticipated increases in costs or expenses; and risks
associated with international operations. Information on these and
additional risks, uncertainties, and other information affecting
our business and operating results can be found in our existing and
future filings with the Securities and Exchange Commission. These
forward-looking statements speak only as of the date hereof. We
disclaim any obligation to update these forward-looking statements
except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of
companies, is a next-generation, evidence-based, personalized
healthcare company enabling improved patient outcomes and more
effective treatment decisions for critical illnesses. NantHealth's
unique systems-based approach to personalized healthcare applies
novel diagnostics tailored to the specific molecular profiles of
patient tissues and integrates this molecular data in a clinical
setting with large-scale, real-time biometric signal and phenotypic
data to track patient outcomes and deliver precision medicine. For
nearly a decade, NantHealth has developed an adaptive learning
system, which includes its unique software, middleware and hardware
systems infrastructure that collects, indexes, analyzes and
interprets billions of molecular, clinical, operational and
financial data points derived from novel and traditional sources,
continuously improves decision-making and further optimizes our
clinical pathways and decision algorithms over time. For more
information please visit www.nanthealth.com and follow
Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180305006139/en/
NantHealth Media ContactNantWorksJen
Hodsonjhodson@nantworks.com
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Jun 2024 to Jul 2024
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Jul 2023 to Jul 2024